Marketing-authorisation holder · United States
Mylan
67 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
67 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 67
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABACAVIR SULFATE300mg | 300mg base | 60 mg | 60mg · Tablet | Abacavir | United States | Marketed | 2007 |
| ALOPRIM500mg base/vial · Injectable | Allopurinol | United States | Marketed | 1996 |
| AMNESTEEM10mg | 20mg | 30mg | 40mg · Capsule | Isotretinoin | United States | Marketed | 2002 |
| AMOXICILLIN250mg | 500mg · Capsule | Amoxicillin | United States | Marketed | 1976 |
| APREPITANT32mg/4.4ml (7.2mg/ml) · Emulsion | Aprepitant | United States | Not marketed | 2026 |
| ARIPIPRAZOLE300mg/vial | 400mg/vial · For suspension, extended release | Aripiprazole | United States | Not marketed | 2024 |
| AVITA0.025% · Cream | Tretinoin | United States | Marketed | 1997 |
| BEPOTASTINE BESILATE1.5% · Solution/drops | Bepotastine | United States | Marketed | 2019 |
| BOSENTAN125mg | 62.5mg · Tablet | Bosentan | United States | Marketed | 2019 |
| BREYNA0.08mg/inh; 0.0045mg/inh | 0.16mg/inh; 0.0045mg/inh · Aerosol, metered | Budesonide, Formoterol | United States | Marketed | 2022 |
| CETIRIZINE HYDROCHLORIDE HIVES10mg | 5mg · Tablet | Cetirizine | United States | Marketed | 2007 |
| CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE12.5mg base; 5mg | 25mg base; 10mg · Tablet | Amitriptyline, Chlordiazepoxide | United States | Marketed | 1986 |
| CHLORDIAZEPOXIDE HYDROCHLORIDE10mg | 25mg | 5mg · Capsule | Chlordiazepoxide | United States | Marketed | 1975 |
| CYSTAGON150mg base | 50mg base · Capsule | Mercaptamine | United States | Marketed | 1994 |
| DARUNAVIR AND RITONAVIR400mg/50mg · Tablet | Darunavir, Ritonavir | United States | Marketed | 2023 |
| DENAVIR1% · Cream | Penciclovir | United States | Marketed | 1996 |
| DEXLANSOPRAZOLE30mg | 60mg · Capsule, delayed release | Dexlansoprazole | United States | Marketed | 2017 |
| DIVALPROEX SODIUM125mg valproic acid | 250mg valproic acid | 500mg valproic acid · Tablet, delayed release | Divalproex | United States | Marketed | 2006 |
| ELETRIPTAN HYDROBROMIDE20mg | 20mg base | 40mg | 40mg base · Tablet | Eletriptan | United States | Marketed | 2013 |
| ENALAPRIL MALEATE10mg | 2.5mg | 20mg | 5mg · Tablet | Enalapril | United States | Marketed | 2000 |
| ERMEZA150mcg/5ml · Solution | Levothyroxine | United States | Marketed | 2022 |
| ERYGEL2% · GEL | Erythromycin | United States | Not marketed | 1987 |
| ETOPOSIDE50mg · Capsule | Etoposide | United States | Marketed | 2001 |
| FLUVASTATIN SODIUM20mg base | 40mg base · Capsule | Fluvastatin | United States | Marketed | 2012 |
| FULPHILA6mg/0.6ml · Injectable | Pegfilgrastim | United States | Marketed | 2018 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 67 | 55 | 12 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.